Resistance patterns with tyrosine kinase inhibitors in melanoma: new insights.

Abstract

PURPOSE OF REVIEW After years of therapeutic approaches with limited effects in metastatic melanoma, new inhibitors of serine-threonine and tyrosine kinases have demonstrated impressive clinical efficacy and improved survival. RECENT FINDINGS This review explains the molecular background for the development of specific kinase inhibitors and briefly summarizes their clinical impact on advanced melanoma. SUMMARY Despite robust early clinical efficacy, the antiproliferative effect of these kinase inhibitors is limited. The resistance mechanisms are explored currently and will help to identify new targets for melanoma therapy.

DOI: 10.1097/CCO.0b013e32834fca92
050100201220132014201520162017
Citations per Year

161 Citations

Semantic Scholar estimates that this publication has 161 citations based on the available data.

See our FAQ for additional information.

Cite this paper

@article{Dummer2012ResistancePW, title={Resistance patterns with tyrosine kinase inhibitors in melanoma: new insights.}, author={Reinhard Dummer and Keith T. Flaherty}, journal={Current opinion in oncology}, year={2012}, volume={24 2}, pages={150-4} }